Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-03-29
2011-03-29
Kelly, Robert M (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S455000, C530S358000
Reexamination Certificate
active
07915230
ABSTRACT:
Compositions and methods for improved delivery of macromolecules into eukaryotic cells are provided. Fusogenic peptides from fusion proteins of non-enveloped viruses enhance the efficiency of transfection of eukaryotic cells mediated by transfection agents such as cationic lipids, polycationic polymers such as PEI and dendrimers. These fusogenic peptides are used as part of a transfection complex that efficiently delivers a macromolecule, for example, a nucleic acid, into a eukaryotic cell. Novel cationic lipids and compositions of cationic lipids also are provided that may be used for the introduction of macromolecules such as nucleic acids, proteins and peptides into a variety of cells and tissues. The lipids can be used alone, in combination with other lipids and/or in combination with fusogenic peptides to prepare transfection complexes.
REFERENCES:
patent: 6750058 (2004-06-01), Chroboczek et al.
patent: WO 99/24582 (1999-05-01), None
patent: WO 02/44206 (2002-06-01), None
J.A. Corcoran, et al.; “The p14 Fusion-associated Small Transmembrane (FAST) Protein . . . ”; Journal of Biological Chem. vol. 281, No. 42, pp. 31778-31789; (2006).
D. Top, et al.; “Liposome Reconstitution of a Minimal Protein-Mediated Membrane Fusion Machine”; EMBO Journal, vol. 24, No. 17, pp. 2980-2988; (2005).
M. Shmulevitz, et al.; “Palmitoylation, Membrane-Proximal Basic Residues, and Transmembrane . . . ”; Journal of Virology, vol. 77, No. 18, pp. 9769-9779; (2003).
J.A. Corcoran, et al.; “Reptilian Reovirus Utilizes a Small Type III Protein with an External . . . ”; Journal of Virology, vol. 78, No. 8, pp. 4342-4351; (2004).
M. Shmulevitz, et al.; “Cell-Cell Fusion Induced by the Avian Reovirus Membrane Fusion . . . ”; Journal of Virology, vol. 78, No. 11, pp. 5996-6004; (2004).
M. Shmulevitz, et al.; “Structural and Functional Properties of an Unusual Internal Fusion Peptide . . . ” Journal of Virology, vol. 78, No. 6, pp. 2808-28184; (2004).
S. Dawe, et al.: “Unusual Topological Arrangement of Structural Motifs in the Baboon Reovirus Fusion . . . ”Journal of Virology, vol. 79, No. 10, pp. 6216-6226; 2005.
J.A. Corcoran, et al.; “Myristoylation, a Protruding Loop, and Structural Plasticity Are Essential . . . ”; Journal of Biological Chem. vol. 279, No. 49, pp. 51386-51394; (2004).
L. T. Cheng et al., “Atypical Fusion Peptide of Nelson Bay Virus Fusion-Associated Small Transmembrane Protein” Journal of Virology, vol. 79, p. 1853-1860 (2005).
S. Dawe and R. Duncan “The S4 Genome Segment of Baboon Reovirus Is Bicistronic and Encodes a Novel . . . ” Journal of Virology, vol. 76, pp. 2131-2140 (2002).
M. Shmulevitz and R. Duncan. “A new class of fusion-associated small transmembrane (FAST) proteins . . . ” The EMBO Journal vol. 19, pp. 902-912, (2000).
Gebeyehu Gulilat
Jessee Joel
Kelly Robert M
Molecular Transfer, Inc.
Perkins Coie LLP
LandOfFree
Reagents for transfection of eukaryotic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagents for transfection of eukaryotic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents for transfection of eukaryotic cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2738556